Work

Comparative efficacy and safety of anti-HER2 neoadjuvant therapy in early-stage HER2-positive breast cancer: A real-world multicenter analysis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e12668

Authors: Yuqin Zhou, Juncheng Xuhong, Ya Wei, Maoshan Chen, Mengyuan Wang, Shouman Wang, Liang Xu, Guiying Xu, Yan Liang, Lin Ren, Linjun Fan, Peng Tang, Minghao Wang, Li Chen, Shushu Wang, Jun Jiang, Wenbin Zhou, Yi Zhang, Qiao Cheng, Xiaowei Qi

Institutions: Army Medical University, Southwest Hospital, Chongqing Municipal Health Commission, Anyang Tumor Hospital, Chongqing University, Central South University, Xiangya Hospital Central South University, Nanchang Medical College, Jilin Province Tumor Hospital, Jiangsu Province Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Science and Technology Major Project

Award: G7965595398

OpenAlex ID: W7162695465

Cites:

Cited by:

Related to: